CVS Health Corporation

NYSE:CVS 주식 보고서

시가총액: US$72.2b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

CVS Health 미래 성장

Future 기준 확인 1/6

CVS Health (는) 각각 연간 8.8% 및 4.7% 수익과 수익이 증가할 것으로 예상됩니다. EPS는 연간 10% 만큼 성장할 것으로 예상됩니다. 자기자본이익률은 3년 후 11.8% 로 예상됩니다.

주요 정보

9.4%

수익 성장률

10.1%

EPS 성장률

Healthcare 수익 성장17.2%
매출 성장률4.7%
향후 자기자본 수익률11.8%
애널리스트 커버리지

Good

마지막 업데이트09 Jul 2024

최근 미래 성장 업데이트

CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 03
CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Recent updates

CVS Health: A Better Investment Than Walgreens Boots Alliance

Jul 09

Vltava Fund - CVS Health Corp.: Why We Sold CVS

Jul 03

CVS Health: Mismanagement, Eroding Moat And Poor Momentum Make It A Sell

Jun 21

The Correct Play On CVS Health

Jun 06

CVS Health: Downside Movement Is Overdramatic

May 26

CVS Health: Secure Dividend And Upside Potential Presents Compelling Opportunity

May 15

We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

May 10
We Think Shareholders Are Less Likely To Approve A Pay Rise For CVS Health Corporation's (NYSE:CVS) CEO For Now

CVS Health: A Terrible Earnings Report, But An Undervalued Stock

May 04

CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

May 03
CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

CVS Health: 8x P/E, 8% Growth Projection - It's A Market Blind Spot

Apr 22

Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)

Apr 14
Sentiment Still Eluding CVS Health Corporation (NYSE:CVS)

CVS Health: Lookback, Management Guidance Vs. Results 2018-To-Date

Apr 10

Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

Mar 27
Does CVS Health (NYSE:CVS) Have A Healthy Balance Sheet?

CVS Health: Better Times Likely Ahead

Mar 12

CVS Health: Lower Guidance But Risk/Reward Remains Attractive

Feb 15

CVS Health FY23 Earnings: Downgrades Inevitable, Long Term Outlook In The Balance

Feb 07

CVS Health: Back In The Buy Column

Jan 21

CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

Jan 17
CVS Health (NYSE:CVS) Has Announced That It Will Be Increasing Its Dividend To $0.665

CVS Health: Shares Remain Modestly Undervalued, Robust Free Cash Flow, Technical Strength

Jan 08

CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

Jan 03
CVS Health (NYSE:CVS) Is Paying Out A Larger Dividend Than Last Year

CVS Health: Risk/Reward Highly Skewed To The Upside

Dec 15

CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665

Dec 13
CVS Health (NYSE:CVS) Is Increasing Its Dividend To $0.665

We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt

Dec 08
We Think CVS Health (NYSE:CVS) Is Taking Some Risk With Its Debt

CVS Health: A Good Fit To Buffett's 10x Pretax Rule

Dec 07

CVS Health: Not One Dividend Cut In 30 Years And A Good Upside

Nov 27

CVS Health: All Eyes On December Investor Day

Nov 21

CVS Health Ahead Of Q3 Earnings: Making The Pivot Toward Value-Based Care Work

Oct 26

CVS Health: 'Only' A Fair Company For A Wonderful Price?

Oct 20

수익 및 매출 성장 예측

NYSE:CVS - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/2026410,26610,19311,39314,56315
12/31/2025387,2478,74010,11812,98925
12/31/2024368,8497,4119,23711,88825
3/31/2024359,6627,3218,13910,891N/A
12/31/2023356,6238,34410,39513,426N/A
9/30/2023346,6018,63211,30214,110N/A
6/30/2023338,0722,96517,67420,517N/A
3/31/2023329,9154,09317,39220,052N/A
12/31/2022321,6294,31113,45016,177N/A
9/30/2022314,3433,28319,49822,134N/A
6/30/2022306,9338,28715,86818,532N/A
3/31/2022298,7708,04116,19418,936N/A
12/31/2021290,9128,00115,74518,265N/A
9/30/2021283,9817,58615,19117,827N/A
6/30/2021277,2857,21211,61814,180N/A
3/31/2021270,1157,40412,92815,452N/A
12/31/2020267,9087,18813,42815,865N/A
9/30/2020265,2857,95112,64114,932N/A
6/30/2020262,9808,25713,62815,986N/A
3/31/2020260,9617,21711,72214,205N/A
12/31/2019255,7656,62910,39112,848N/A
9/30/2019243,3314,46410,21812,693N/A
6/30/2019226,0534,3248,44810,862N/A
3/31/2019209,623-1746,1878,458N/A
12/31/2018193,919-5976,8288,865N/A
9/30/2018188,0553,0984,2926,250N/A
6/30/2018186,9672,9895,8227,764N/A
3/31/2018185,9446,6454,8866,829N/A
12/31/2017184,7656,606N/A8,007N/A
9/30/2017182,3515,029N/A10,264N/A
6/30/2017180,7855,281N/A11,587N/A
3/31/2017178,8255,108N/A11,235N/A
12/31/2016177,5265,291N/A10,141N/A
9/30/2016172,7015,084N/A11,591N/A
6/30/2016166,7294,781N/A9,477N/A
3/31/2016160,1735,126N/A8,867N/A
12/31/2015153,2905,202N/A8,539N/A
9/30/2015149,1995,027N/A8,264N/A
6/30/2015145,5774,741N/A8,089N/A
3/31/2015143,0104,713N/A7,949N/A
12/31/2014139,3674,626N/A8,137N/A
9/30/2014135,1424,576N/A6,252N/A
6/30/2014132,0534,887N/A6,310N/A
3/31/2014128,6994,775N/A6,315N/A
12/31/2013126,7614,600N/A5,783N/A
9/30/2013125,3124,450N/A5,976N/A

애널리스트 미래 성장 예측

수입 대 저축률: CVS 의 연간 예상 수익 증가율( 8.8% )이 saving rate( 2.4% 보다 높습니다. ).

수익 vs 시장: CVS 의 연간 수익( 8.8% ) US 시장( 14.9% 보다 느리게 성장할 것으로 예상됩니다. 14.9% 연간).

고성장 수익: CVS 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: CVS 의 수익(연간 4.7% ) US 시장( 8.7% 보다 느리게 성장할 것으로 예상됩니다. 8.7% 연간).

고성장 수익: CVS 의 수익(연간 4.7% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.


주당 순이익 성장 예측


미래 자기자본 수익률

미래 ROE: CVS 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 11.8 %).


성장 기업 발견